These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2137979)

  • 21. Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: the role of cyclic sodium etidronate and low-dose norethindrone "add-back" therapy.
    Surrey ES; Voigt B; Fournet N; Judd HL
    Fertil Steril; 1995 Apr; 63(4):747-55. PubMed ID: 7890057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas.
    Fedele L; Bianchi S; Raffaelli R; Zanconato G
    Eur J Obstet Gynecol Reprod Biol; 2000 Jan; 88(1):91-4. PubMed ID: 10659924
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monthly implant of luteinizing hormone-releasing hormone agonist: a practical therapeutic approach for sex-steroid dependent gynecologic diseases.
    Lemay A
    Fertil Steril; 1987 Jul; 48(1):10-2. PubMed ID: 2954859
    [No Abstract]   [Full Text] [Related]  

  • 24. The use of a gonadotropin-releasing hormone analog and transdermal estrogen to preserve fertility in a woman with severe menorrhagia.
    Fedorkow DM; Corenblum B; Shaffer EA
    Fertil Steril; 1989 Sep; 52(3):512-3. PubMed ID: 2528478
    [No Abstract]   [Full Text] [Related]  

  • 25. Magnetic resonance imaging of leiomyomata uteri: assessing therapy with the gonadotropin-releasing hormone agonist leuprolide.
    Lubich LM; Alderman MG; Ros PR
    Magn Reson Imaging; 1991; 9(3):331-4. PubMed ID: 1908932
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Add-back therapy in the treatment of endometriosis: the European experience.
    Edmonds DK
    Br J Obstet Gynaecol; 1996 Oct; 103 Suppl 14():10-3. PubMed ID: 8916980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Effects of Gonadotropin-Releasing Hormone Agonists and Add-Back in Adolescent Endometriosis.
    Gallagher JS; Missmer SA; Hornstein MD; Laufer MR; Gordon CM; DiVasta AD
    J Pediatr Adolesc Gynecol; 2018 Aug; 31(4):376-381. PubMed ID: 29551430
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of danazol, gonadotropin-releasing hormone agonist, and a combination of danazol and gonadotropin-releasing hormone agonist on experimental endometriosis.
    Sakata M; Terakawa N; Mizutani T; Tanizawa O; Matsumoto K; Terada N; Sudo K
    Am J Obstet Gynecol; 1990 Nov; 163(5 Pt 1):1679-84. PubMed ID: 2122726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
    Malik M; Britten J; Cox J; Patel A; Catherino WH
    Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Monitoring therapy with a gonadotropin-releasing hormone analog: utility of MR imaging.
    Zawin M; McCarthy S; Scoutt L; Lange R; Lavy G; Vulte J; Comite F
    Radiology; 1990 May; 175(2):503-6. PubMed ID: 2109336
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintained reduction of uterine leiomyoma following addition of hormonal replacement therapy to a monthly luteinizing hormone-releasing hormone agonist implant: a pilot study.
    Maheux R; Lemay A; Blanchet P; Friede J; Pratt X
    Hum Reprod; 1991 Apr; 6(4):500-5. PubMed ID: 1655823
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of steroid add-back therapy on the proliferative activity of uterine leiomyoma cells under gonadotropin-releasing hormone agonist therapy.
    Mizutani T; Sugihara A; Honma H; Komura H; Nakamuro K; Terada N
    Gynecol Endocrinol; 2005 Feb; 20(2):80-3. PubMed ID: 15823826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis.
    Irahara M; Uemura H; Yasui T; Kinoshita H; Yamada M; Tezuka M; Kiyokawa M; Kamada M; Aono T
    Gynecol Obstet Invest; 2001; 52(4):217-22. PubMed ID: 11729332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term gonadotropin-releasing hormone agonist therapy: the evolving issue of steroidal "add-back" paradigms.
    Adashi EY
    Keio J Med; 1995 Dec; 44(4):124-32. PubMed ID: 8587224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies on endocrine therapy of endometriosis].
    Terakawa N
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Aug; 41(8):981-9; discussion 1000-7. PubMed ID: 2530291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [GnRH-agonists in the therapy of endometriosis].
    Hoffmann G; Spitz J; Behrens R
    Ther Umsch; 1990 Dec; 47(12):937-44. PubMed ID: 2128966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extending the use of gonadotropin-releasing hormone agonists: the emerging role of steroidal and nonsteroidal agents.
    Lemay A; Surrey ES; Friedman AJ
    Fertil Steril; 1994 Jan; 61(1):21-34. PubMed ID: 8293841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of gonadotrophin-releasing hormone analogues in gynaecology.
    Lo KW; Lau TK
    Chin Med J (Engl); 1997 Oct; 110(10):746-9. PubMed ID: 9642302
    [No Abstract]   [Full Text] [Related]  

  • 40. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.